Aim A global question on chronic morbidity is included in many national health interview surveys. According to a recent EU Commission regulation, information on this item should be collected in all EU member states. However, little is known about the reliability and validity of such a question. Subject and methods The reliability of a global question on chronic morbidity was investigated among persons who participated in 2001 in both the Belgian health interview survey (HIS) and the national population census (n=2,871) by using kappa statistics and logistic regression. In addition, data from the HIS 2001 and 2004 (n=21,376) were used to study estimates and determinants of the sensitivity of this global chronic morbidity measure among people with specific chronic diseases. Results In terms of reliability, the kappa statistic showed only moderate agreement (0.559; 95 % CI 0.523-0.594). Additionally, the sensitivity of the global question on chronic morbidity ranged from 49.9 to 87.2 %, depending on the type of disease. A much higher sensitivity was observed among people who rated their health status to be moderate to bad (adjusted OR 3.85;). Conclusion Self-reported chronic morbidity, measured by a single and global question, is a reasonably reliable instrument to measure ill health. The global instrument provides useful information on the burden of disease, because it takes into account the relevance of the diseases for the people themselves.
Introduction
Chronic diseases are the largest cause of death in the world and contribute substantially to the burden of disability (Murray et al. 2012) . Moreover, deaths from chronic diseases are projected to increase dramatically between now and 2030 (Mathers and Loncar 2006) . Chronic diseases have a significant impact on the quality of life of those affected and their families and are a major driver of health care costs, especially in case of multimorbidity.
To describe the burden of disease, calculate health indicators that measure life expectancy in relation to health status, and assess differences in ill health between population groups, concise, population-based information on the prevalence of chronic morbidity is needed. This information can be collected most easily through one global question in a population survey. An example of such question is: "Do you suffer from any chronic illness or condition?" This question is part of the Minimum European Health Module (MEHM), an instrument developed in the framework of the Euro-REVES project, with global questions on perceived health, chronic morbidity and activity limitation. The MEHM is included in the European Survey on Income and Living Conditions (EU-SILC) and the European Health Interview Survey (EHIS). The module allows collecting information on items for which, according to an EU Commission Regulation 1 , European member states are bound to provide data to Eurostat. Even though the EHIS regulation was only published in February 2013, global questions on chronic morbidity had been used in many national health surveys in Europe well before this time (Aromaa et al. 2003) . In the UK, a global question on chronic morbidity has been included in the General Household Survey (GHS) since 1971 (Macintyre et al. 2005) . In Belgium, information on this item has been collected since the first national Health Interview Survey in 1997 (Demarest et al. 2013) .
The most straightforward indicator that is derived from such a global question is the prevalence of self-reported chronic morbidity. This indicator has been included in the shortlist of the European Core Health Indicators (ECHI), which is a comprehensive list of public health indicators at the EU level (Verschuuren et al. 2013) . Another indicator based on this question is life expectancy with and without chronic morbidity. The algorithm to calculate this indicator is based on the Sullivan method (Sullivan 1971) and was developed by Eurostat in collaboration with the European Health Expectancy Monitoring Unit (EHEMU). EU-SILC data have been used to calculate the prevalence of chronic morbidity and life expectancy with and without chronic morbidity in 25 EU member states (Jagger et al. 2008) .
Although the validity and reliability of self-reported health status measures have been studied extensively, up to now most research has focussed on self-rated health. This concept, which is measured with the question, "How do you rate your health in general?", appears to be an excellent predictor of mortality, morbidity, functional status, disability and health consumption (de Bruin et al. 1996) . Furthermore, several studies have assessed the validity of specific self-reported chronic diseases (Martin et al. 2000) . The results depend on the type of disease; a specificity of 90 % or higher is found for self-reported diabetes, hypertension, stroke, cancer and asthma (Engstad et al. 2000; Fowles et al. 1998 ); in contrast, for self-reported arthritis, hypothyroidism, hyperthyroidism and acne, the specificity is less than 75 % (Bombard et al. 2005; Brix et al. 2001; Menon et al. 2008) .
Compared to the question on self-rated health, the global question to measure self-reported chronic morbidity has been studied far less. Conceptual work has been done by Robine et al. (2002) and Burata et al. (2003) . Cox et al. (2009) assessed the reliability of the MEHM in a small sample. However, to date, no large-scale studies are available that investigate both the reliability and validity of a global question on chronic morbidity at the population level.
Therefore, the main aim of this study was to assess the reliability and validity of a global question on self-reported chronic morbidity within a large and representative sample of the general population. An additional aim was to investigate to what extent the reliability and validity of this question varied in the function of sociodemographic and interview-related background characteristics.
Methods

Data
In Belgium, national health interview surveys (HIS) have been organised periodically since 1997, with intervals varying between 3 and 5 years. For this study, data were used from the respondents, aged 15 years and older, participating in the HIS 2001 (n=10,156) and HIS 2004 (n=11,220) . The HIS 2001 and HIS 2004 are independent cross-sectional surveys. The sampling frame is the national register. The probability of the same person being selected for both surveys is negligible (approximately 1/1,000,000).
In the HIS, information is collected on the health status, lifestyle and health care utilisation of a representative sample of the total Belgian population. The face-to-face questionnaire includes a global question on chronic morbidity. The exact formulation of this question is: "Do you have a longstanding disease, condition or handicap? (yes/no)?" This question differs from the question in the MEHM, because at the time the first health survey was conducted in Belgium in 1997, the MEHM question was not yet available. To be able to follow time trends, the original question has been consistently used in all consecutive health surveys.
The same question was also included in the national Belgian population census of 2001. Participation in the census was mandatory for all Belgian residents (n=10, 263, 414) . For the respondents, aged 15 years and older, who participated between September 2001 and January 2002 in both the HIS and the census (n=2,871), an individual data linkage was performed between the HIS 2001 data and the answer to the global question on chronic morbidity in the census, using the National Population Register ID as key variable.
Three types of variables were identified as potential determinants of the reliability and validity of self-reported chronic morbidity: (1) sociodemographic variables (gender, age, educational attainment, nationality); (2) health-related variables (type and number of specific self-reported chronic diseases, self-rated health, mental health); (3) an interview-related variable (self-reporting versus proxy-interview).
Educational attainment was defined at the level of the household. Information on specific chronic diseases and conditions was obtained by asking whether the person had suffered from that particular disease during the 12 months preceding the survey. Mental health was measured using the General Health Questionnaire (GHQ) (Goldberg and Williams 1988) in its short version . This questionnaire assesses the notion of "general sufferance as a unique and global morbid class", i.e. psychological distress. A score of 4 or more indicates the presence of psychological problems, probably calling for professional help. The indicators on mental health and self-rated health were based on questions in the self-administered questionnaire. Therefore, no information on these indicators was available for respondents for whom the information was collected via a proxy-interview (5.9 % of respondents), because completing a self-administered questionnaire for those interviews was not authorised.
Analysis
For the respondents who participated in both the HIS and the census, the reliability of the answer to the question "Do you have a long standing disease, condition or handicap?" between the HIS and census was investigated via kappa statistics. Determinants of responding inconsistently were assessed through logistic regression.
For the validity calculations, combined data of the HIS 2001 and the HIS 2004 were used. In the assessment of the validity of an instrument, different aspects can be considered: content validity, face validity, correlational validity and criterion validity (McDowell and Newell 1996) . Criterion validity considers whether the instrument correlates highly with a "gold standard". This was the approach followed in the current study, with having a specific chronic disease as a "gold standard". In a first step, a selection was made of specific chronic diseases included in the HIS for which selfreported information was estimated to be sufficiently accurate. This was assessed by searching PubMed, Embase and Scopus for studies published up to January 2013, using the following search strategy: "self-report" AND "validity" AND "(morbidity OR disease)" AND "survey". This search strategy yielded 2,001 references. Based on the title, and if the title alone was not sufficient, the abstract, 41 articles were retrieved and full-text screened. In 27 papers results were reported on the specificity of one or more self-reported chronic diseases included in the list of diseases in the HIS questionnaire. Chronic diseases were eligible for inclusion if literature findings were available that pointed out that the specificity of self-reported information for that disease, defined as the number of true negatives divided by the number of true negatives and false positives, was at least 80 %, using medical records or clinical measurements as the gold standard. For the sensitivity analyses we focussed on respondents with at least one of the selected specific chronic diseases. A true positive was defined as a person who had responded positively to the global question on chronic morbidity, a false negative a person who had answered negatively to this question; the sensitivity was then calculated as the true positives divided by the true positives and the false negatives. In a final step, a multivariate analysis was performed to verify whether the sensitivity varied significantly in the function of potential determinants. Information on self-rated and mental health, which was collected via a self-administered questionnaire, was not available for respondents who were interviewed via a proxy. Therefore, proxy interviews (n=112) were excluded from the multivariate analyses. All analyses were carried out with Stata/SE 10.1 (StataCorp, College Station, TX). Estimates and standard errors were calculated, taking into account the stratified, clustered sampling design of the HIS.
Results
General agreement between the HIS and census
Among the 2,871 respondents who participated in the last quarter of 2001 in both the HIS and the census, the prevalence of self-reported chronic morbidity was 28.4 % (95 % CI 25.9-30.9 %) according to the HIS and 26.3 % (95 % CI 23.6-29.2 %) according to the census (Table 1) . A discordant result was found in 469 (18.2 %) of the 2,626 participants for whom valid information on the global question of chronic morbidity was available in both data sources. Accordingly, the kappa statistic showed only a moderate agreement (0.559; 95 % CI 0.523-0.594).
Results by gender, age, self-rated health, GHQ score, education, nationality and type of respondent (Table 1) revealed that the reliability did not vary greatly by subgroup, except among persons with a GHQ score of 4 or more (kappa 0.631; 95 % CI 0.596-0.667), who showed a substantially higher reliability than persons with a GHQ score between 0 and 3 (kappa 0.526; 95 % CI 0.488-0.565). Non-Belgian citizens (kappa 0.417; 95 % CI 0.379-0.456) showed a substantially lower reliability than Belgians ones (kappa 0.574; 95 % CI 0.539-0.609).
In a multivariate analysis, investigating the discrepancy between the HIS and population census, only age emerged as a significant factor (Table 2) . Increasing age was clearly associated with a higher discrepancy of the results. The odds ratio for the age group of 65 years and older was 2.57 (95 % CI 1.29-5.12) compared to the reference category of 15-24 years.
Neither mental health nor self-rated health appeared to have an impact on the reliability of self-reported chronic morbidity.
Disease-specific consistency in reporting
From the literature findings, it appeared that for ten specific chronic diseases that were included in the HIS, the specificity of self-reported prevalence compared to clinical measurement or medical records was at least 80 %: asthma, hypertension, serious heart disease or heart attack, stroke, diabetes mellitus, epilepsy, Parkinson's disease, cataract, glaucoma, and malignant neoplasm or cancer. The outcome of the literature review is presented in more detail in Table 3 . (Table 4) , and for each disease was substantially higher for people who consider their health to be moderate or bad than for those who consider themselves to be in good health. Figure 1 shows the increase in the sensitivity of the global chronic morbidity measure in the function of the number of reported diseases. If one disease was reported, the sensitivity was 52.3 % in males and 53.2 % in females. In case of three reported diseases, the sensitivity was around 80 %. Only from the presence of five diseases in females and six diseases in males onwards was the sensitivity 100 %.
Unlike the reliability, the sensitivity of the global chronic morbidity measure varied far more in the function of background characteristics (Table 5 ). The sensitivity was significantly higher in people indicating that their subjective health was moderate to bad (OR 3.85; 95 % CI 3.17-4.69 compared to those estimating their health to be good to very good). It was significantly lower in non-Belgians (OR 0.60; 95%CI 0.41-0.86 compared to Belgians). Diseases that were strongly associated with a higher sensitivity were epilepsy, stroke, cancer, asthma, diabetes, and serious heart disease or heart attack. Also, a GHQ score of 4 or more was significantly associated with a higher sensitivity (OR 1.34; 95 % CI 1.02-1.75 compared to those with a GHQ below 4).
Discussion
According to criteria proposed by Landis and Koch (1977) , the overall kappa value of the global question on self-reported chronic morbidity in this study is moderate, and lower than expected, especially in comparison with the results from Cox et al. (2009) or those from an Australian study assessing the reliability of self-reported specific chronic conditions (Dal Grande et al. 2012) . The relatively low reliability may be related to the difference in the mode of data collection between the HIS and the population census. In the survey methodology, it is well known that the quality of the data is affected by the mode of data collection (Groves et al. 2004) . However, in the HIS, data were collected via a face-to-face interview, census information was initially collected via a postal survey, and only in case of non-response did an interviewer visit the respondent for a face-to-face interview. Other methodological reasons why people may have answered in a discordant way could be: differences in the focus of the survey (health versus socioeconomic information), length of the questionnaire and the mandatory nature of the census. The difference in the mode of data collection between the HIS and census may also have affected the results on the discrepancy in self-reported chronic morbidity in function of background characteristics, which are presented in Table 2 . For example, this is possible if the impact of the mode of the data collection is more important for one population group than for another. In international comparisons of survey results, the impact of the data collection mode, which is assumed to be a major explanatory factor of the relatively low reliability in our study, is often insufficiently considered. During the last decade, both the WHO and Eurostat have made major efforts toward the harmonisation of instruments in health surveys at the European level. Nevertheless, it is unfortunate that in the current EU Commission EHIS regulation, no guidelines are included on the exact formulation of the questions nor on the data collection mode. Not only does this under-valorise the huge amount of preparatory work that has been done in the field of preharmonisation of the questions, but it also substantially jeopardises the international comparability of the data that are submitted to Eurostat, including those on self-reported chronic morbidity. The sensitivity of the global chronic morbidity measure depends strongly on the type of specific disease. The impact of a disease, in terms of symptoms and effect on the daily living, may substantially affect the people's judgment on whether they consider themselves to have a chronic disease or not. This may explain why only half of the patients with hypertension, who often present without any symptoms, report having a chronic disease via the global question.
Although the analyses were restricted to diseases for which there is evidence in the literature that self-reports are sufficiently valid, the use of self-reported information as the gold standard is definitely a weakness. Also the assumption that self-reported information is valid when it is confirmed by medical records or clinical measurements may not be completely true. The information from medical records may be incomplete and clinical measurements may vary over time. However, in the absence of more objective information, the use of self-reported chronic diseases as the gold standard was the best option that could be taken. Another weakness is that the specificity of the global question could not be tested, because the information on specific chronic diseases in the HIS is not exhaustive. Hence, it was not possible to identify false positives, i.e. persons answering positively to the global question on chronic morbidity without having a specific chronic disease.
An important strength of this study is that it was conducted in a large, representative sample of the total population. Seasonal effects, which could have affected the results on the reliability, were avoided by including only persons who participated within the same 4-month period in both the census and HIS. Proxy interviews were included as well. It is remarkable that the reliability of self-reported chronic morbidity was quite similar for respondents who answered themselves and via proxy respondents. However, this result should be interpreted with caution. The number of proxy respondents was low, and the impact of a proxy interview could not be adjusted for subjective and mental health, because for those respondents no self-administered questionnaire was available.
Some determinants of the validity and reliability of self-reported chronic morbidity appear to be the same as those identified in studies assessing the reliability and validity of self-rated health. This applies for age (Crossley and Kennedy 2002; Zajacova and Dowd 2011) and nationality (Bombak and Bruce 2012) , and to some extent to gender (Deeg and Kriegsman 2003) . Higher age is associated with lower reliability, but not with a different validity. Nationality has no impact on the reliability, but among respondents with one or more specific chronic diseases, non-national citizens answer positively to the global question on chronic disease significantly less often. The sensitivity of the global chronic morbidity measure is also lower in females than in males. Perhaps the perception of what a Men Women % self reported chronic morbidity Number of specific chronic diseases among the ten diseases that were selected Fig. 1 Sensitivity of the global chronic morbidity measure in the function of the number of reported specific chronic diseases chronic disease is may vary among different population groups. After adjustment for age, gender and nationality, our study did not point out any educational differences. Our data thus support the hypothesis that a global question in a health survey is suitable to estimate socioeconomic status gradients in chronic morbidity, which is in line with the findings of Macintyre et al. (2005) .
Although chronic diseases include essentially cardiovascular diseases, cancer, chronic respiratory diseases and diabetes (Horton 2005) , this list is not exhaustive (Piot and Ebrahim 2010) and especially lay people might interpret this arbitrarily. Still, it is reassuring that a strong, significant and independent association was found between the global question on chronic morbidity and most of the specific chronic diseases that were selected. Also, a sharp increase in the sensitivity of the function of the number of specific chronic conditions confirms the value of this indicator as a global measure of chronic morbidity. Table 4 indicates that the sensitivity of the global chronic morbidity measure is substantially higher among people who assess their subjective health as bad to very bad than among those who consider themselves to be in good health. The difference is particularly high for persons with hypertension, cataracts and glaucoma. It is remarkable that especially those diseases show only a weak or no association with self-reported chronic morbidity. These findings support the hypothesis that the question on chronic morbidity in an HIS covers the concept of "illness" more than that of "disease". Illness is defined as the ill health with which people identify themselves. In contrast, disease is a condition that is defined by a physician or another medical expert (Wikman et al. 2005) . It may be that respondents only identify a specific chronic disease or condition as a chronic illness if this disease has a clear impact on their living situation in terms of suffering or other inconveniences.
The subjective component of a global question on chronic morbidity should not be taken in a negative way. Subjective judgments should be considered a valid approach to measurement. Biases inherent in subjective judgments do not threaten the validity of the measurement process: health, or quality of life, is inherently subjective and is as the patient perceives it (McDowell and Newell 1996) . The interpretation of the concept of chronicity may also vary among respondents, albeit the word "longstanding" is clear enough to assume that only diseases with a duration of at least a couple of months are considered.
Unfortunately, there are no easy recipes to increase the reliability and validity of a global question on chronic morbidity. It is clear that unambiguous and specific questions are more reliable and valid than global, less precise questions. Further research should aim to increase our understanding of the way in which the concept of chronic morbidity based on one global question in a survey relates to objective measures of chronic morbidity. Such research should include cognitive testing and physical examinations or linkage with chronic disease registers.
Conclusion
Self-reported chronic morbidity, measured by a single and global question, is a reasonably reliable instrument to measure ill health, but for the comparison over time or between countries, standardised methods of data collection are essential. The instrument seems to underestimate the prevalence of persons with chronic diseases based on medical diagnoses, a Suffering from at least one of the following specific chronic diseases: asthma, serious heart diseases, hypertension, stroke, cancer, diabetes, Parkinson's disease, epilepsy, cataract, glaucoma but provides useful information on the burden of disease, because it takes into account the relevance of these diseases for the people themselves. This relevance may be related to the impact of the disease on their daily living situation in various ways: functional limitations, pain, financial and social consequences, etc. Therefore, self-reported chronic morbidity cannot substitute information on chronic diseases in medical registries, but is complementary. The relatively easy way to obtain this type of information is definitely an advantage.
